Investigation raises concerns about poor FDA oversight of clinical trials
Investigation raises concerns about poor FDA oversight of clinical trials
16 November 2022Study suggests need for improved support for transgender and non-binary young people after hospitalization
16 November 2022Investigation raises concerns about poor FDA oversight of clinical trials
COVID-19 vaccines and drugs were developed at “warp speed” and now experts are concerned about the US Food and Drug Administration’s (FDA) inadequate surveillance of clinical trial sites, reports an investigation published by The BMJ today.
